Drug intelligence / Profile preview

Lactiferon derma

Development stage
Unknown
Lead developer
Meditrina Pharmaceuticals
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

Lactiferon derma is an oral food supplement developed by MEDITRINA Pharmaceuticals for dermatological support, specifically targeting conditions such as acne vulgaris and rosacea. It is formulated as gastro-resistant (enteric-coated) tablets to ensure optimal absorption of its active ingredients in the intestine. The product contains a combination of lactoferrin (100 mg), zinc gluconate (15 mg elemental zinc), nicotinamide (300 mg), and copper (1 mg elemental copper). Lactoferrin, a multifunctional glycoprotein, provides antimicrobial and anti-inflammatory properties, while zinc and nicotinamide contribute to sebum regulation and the reduction of skin inflammation. The supplement is marketed for its antibacterial, anti-inflammatory, and antiseborrheic effects and can be used as monotherapy or as an adjunct to topical or systemic dermatological treatments.

Brand names
Lactiferon derma
Other names
Lactiferon Derma

Beyond the preview

Go deeper on Lactiferon derma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactiferon derma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call